Jill Feldman discusses the background of the phase 2 COCOON trial in advanced non–small cell lung cancer with EGFR mutations.

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech', 6990.HK) today announced that results from its ...

The number of lung cancer cases in people who have never smoked is increasing. The disease is different from lung cancer ...

and hold promise to further boost the median survival of patients with EGFR mutated NSCLC. Mutation; Lung cancer; Non-small-cell lung cancer; EGFR; EGFR inhibitor; Precision therapies; Resistance Pie ...

An ongoing clinical trial called "BREAKWATER" is showing great promise for metastatic colon cancer patients with a particular ...